Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael J Marks

TitleProfessor-Research
InstitutionUniversity of Colorado Boulder
DepartmentPsych-Psychology
Phone492-9677

    Collapse Research 
    Collapse research activities and funding
    R01DA003194     (MARKS, MICHAEL J)Sep 30, 1983 - Apr 30, 2014
    NIH/NIDA
    Genetics of Nicotine Tolerance: Role of Receptors
    Role: Principal Investigator

    R03AA008388     (MARKS, MICHAEL J)Sep 29, 1989 - Sep 28, 1990
    NIH/NIAAA
    ETHANOL/NICOTINE/CHOLINERGIC RECEPTOR INTERACTION
    Role: Principal Investigator

    R01DA012242     (WHITEAKER, PAUL)Feb 1, 1999 - Aug 31, 2014
    NIH/NIDA
    Alpha-Conotoxin MII: A Selective Nicotinic Receptor Probe
    Role: Co-Principal Investigator

    P30DA015663     (MARKS, MICHAEL J)May 1, 2003 - Apr 30, 2014
    NIH/NIDA
    Studies with Nicotinic Null Mutant Mice
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Moretti M, Fasoli F, Gotti C, Marks MJ. Reduced a4 subunit expression in a4+- and a4+- /ß2+- nicotinic acetylcholine receptors alters a4ß2 subtype up-regulation following chronic nicotine treatment. Br J Pharmacol. 2017 Jun 05. PMID: 28585241.
      View in: PubMed
    2. McClure-Begley TD, Esterlis I, Stone KL, Lam TT, Grady SR, Colangelo CM, Lindstrom JM, Marks MJ, Picciotto MR. Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex. eNeuro. 2016 Jul-Aug; 3(4). PMID: 27559543; PMCID: PMC4985585.
    3. Shanthikumar S, Clifford A, Massie J, Cole T, Steer A, Marks M, Gwee A. Community-acquired pneumonia in children: what to do when there is no response to standard empirical treatment? Thorax. 2016 Oct; 71(10):957-9. PMID: 27503231.
      View in: PubMed
    4. Ondachi PW, Castro AH, Luetje CW, Wageman CR, Marks MJ, Damaj MI, Mascarella SW, Navarro HA, Carroll FI. Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues. ACS Chem Neurosci. 2016 Jul 20; 7(7):1004-12. PMID: 27166021.
      View in: PubMed
    5. Zaikman Y, Marks MJ, Young TM, Zeiber JA. Gender Role Violations and the Sexual Double Standard. J Homosex. 2016 Dec; 63(12):1608-1629. PMID: 26930471.
      View in: PubMed
    6. Pistillo F, Fasoli F, Moretti M, McClure-Begley T, Zoli M, Marks MJ, Gotti C. Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner. Pharmacol Res. 2016 Jan; 103:167-76. PMID: 26631628.
      View in: PubMed
    7. Locker AR, Marks MJ, Kamens HM, Klein LC. Exposure to nicotine increases nicotinic acetylcholine receptor density in the reward pathway and binge ethanol consumption in C57BL/6J adolescent female mice. Brain Res Bull. 2016 May; 123:13-22. PMID: 26428091; PMCID: PMC4814345 [Available on 05/01/17].
    8. Marks MJ, O'Neill HC, Wynalda-Camozzi KM, Ortiz NC, Simmons EE, Short CA, Butt CM, McIntosh JM, Grady SR. Chronic treatment with varenicline changes expression of four nAChR binding sites in mice. Neuropharmacology. 2015 Dec; 99:142-55. PMID: 26192545; PMCID: PMC4655142 [Available on 12/01/16].
    9. Zambrano CA, Short CA, Salamander RM, Grady SR, Marks MJ. Density of a4ß2* nAChR on the surface of neurons is modulated by chronic antagonist exposure. Pharmacol Res Perspect. 2015 Mar; 3(2):e00111. PMID: 25729578; PMCID: PMC4324685.
    10. Meyers EE, Loetz EC, Marks MJ. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment. Pharmacol Biochem Behav. 2015 Mar; 130:1-8. PMID: 25560939; PMCID: PMC4336781.
    11. Stoker AK, Marks MJ, Markou A. Null mutation of the ß2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice. Eur J Pharmacol. 2015 Apr 15; 753:146-50. PMID: 25107281; PMCID: PMC4318782.
    12. Sanjakdar SS, Maldoon PP, Marks MJ, Brunzell DH, Maskos U, McIntosh JM, Bowers MS, Damaj MI. Differential roles of a6ß2* and a4ß2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice. Neuropsychopharmacology. 2015 Jan; 40(2):350-60. PMID: 25035086; PMCID: PMC4443947.
    13. McClure-Begley TD, Grady SR, Marks MJ, Collins AC, Stitzel JA. Presynaptic GABAB autoreceptor regulation of nicotinic acetylcholine receptor mediated [(3)H]-GABA release from mouse synaptosomes. Biochem Pharmacol. 2014 Sep 01; 91(1):87-96. PMID: 24953818; PMCID: PMC4140098.
    14. Marks MJ, Grady SR, Salminen O, Paley MA, Wageman CR, McIntosh JM, Whiteaker P. a6ß2*-subtype nicotinic acetylcholine receptors are more sensitive than a4ß2*-subtype receptors to regulation by chronic nicotine administration. J Neurochem. 2014 Jul; 130(2):185-98. PMID: 24661093; PMCID: PMC4107044.
    15. Gupta RK, Marks M, Edwards SG, Smith K, Fletcher K, Lee SM, Ramsay A, Copas AJ, Miller RF. A declining CD4 count and diagnosis of HIV-associated Hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis? PLoS One. 2014; 9(2):e87442. PMID: 24504076; PMCID: PMC3913599.
    16. Stevens KE, Choo KS, Stitzel JA, Marks MJ, Adams CE. Long-term improvements in sensory inhibition with gestational choline supplementation linked to a7 nicotinic receptors through studies in Chrna7 null mutation mice. Brain Res. 2014 Mar 13; 1552:26-33. PMID: 24462939; PMCID: PMC4405170.
    17. Wageman CR, Marks MJ, Grady SR. Effectiveness of nicotinic agonists as desensitizers at presynaptic a4ß2- and a4a5ß2-nicotinic acetylcholine receptors. Nicotine Tob Res. 2014 Mar; 16(3):297-305. PMID: 24052501; PMCID: PMC3920335.
    18. Marks MJ, Trafimow D, Rice SC. Attachment-related individual differences in the consistency of relationship behavior interpretation. J Pers. 2014 Jun; 82(3):237-49. PMID: 23750636.
      View in: PubMed
    19. McClure-Begley TD, Stone KL, Marks MJ, Grady SR, Colangelo CM, Lindstrom JM, Picciotto MR. Exploring the nicotinic acetylcholine receptor-associated proteome with iTRAQ and transgenic mice. Genomics Proteomics Bioinformatics. 2013 Aug; 11(4):207-18. PMID: 23891776; PMCID: PMC3806329.
    20. Jin Y, Su QX, Shen JX, Marks MJ, Wu J. Impaired hippocampal theta oscillations in the mice null alpha7 nicotinic acetylcholine receptors. CNS Neurosci Ther. 2013 Sep; 19(9):721-3. PMID: 23795917.
      View in: PubMed
    21. Marks MJ. Genetic matters: thirty years of progress using mouse models in nicotinic research. Biochem Pharmacol. 2013 Oct 15; 86(8):1105-13. PMID: 23747348; PMCID: PMC4329927.
    22. Soll LG, Grady SR, Salminen O, Marks MJ, Tapper AR. A role for a4(non-a6)* nicotinic acetylcholine receptors in motor behavior. Neuropharmacology. 2013 Oct; 73:19-30. PMID: 23688922; PMCID: PMC3784255.
    23. Sandry J, Trafimow D, Marks MJ, Rice S. Adaptive memory: evaluating alternative forms of fitness-relevant processing in the survival processing paradigm. PLoS One. 2013; 8(4):e60868. PMID: 23585858; PMCID: PMC3621967.
    24. Sala M, Braida D, Pucci L, Manfredi I, Marks MJ, Wageman CR, Grady SR, Loi B, Fucile S, Fasoli F, Zoli M, Tasso B, Sparatore F, Clementi F, Gotti C. CC4, a dimer of cytisine, is a selective partial agonist at a4ß2/a6ß2 nAChR with improved selectivity for tobacco smoking cessation. Br J Pharmacol. 2013 Feb; 168(4):835-49. PMID: 22957729; PMCID: PMC3631374.
    25. Busman-Sahay K, Drake L, Sitaram A, Marks M, Drake JR. Cis and trans regulatory mechanisms control AP2-mediated B cell receptor endocytosis via select tyrosine-based motifs. PLoS One. 2013; 8(1):e54938. PMID: 23372794; PMCID: PMC3553015.
    26. O'Neill HC, Laverty DC, Patzlaff NE, Cohen BN, Fonck C, McKinney S, McIntosh JM, Lindstrom JM, Lester HA, Grady SR, Marks MJ. Mice expressing the ADNFLE valine 287 leucine mutation of the ?2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function. Pharmacol Biochem Behav. 2013 Jan; 103(3):603-21. PMID: 23123803; PMCID: PMC3544981.
    27. Mackey ED, Engle SE, Kim MR, O'Neill HC, Wageman CR, Patzlaff NE, Wang Y, Grady SR, McIntosh JM, Marks MJ, Lester HA, Drenan RM. a6* nicotinic acetylcholine receptor expression and function in a visual salience circuit. J Neurosci. 2012 Jul 25; 32(30):10226-37. PMID: 22836257; PMCID: PMC3432940.
    28. Smathers RL, Fritz KS, Galligan JJ, Shearn CT, Reigan P, Marks MJ, Petersen DR. Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics. PLoS One. 2012; 7(6):e38459. PMID: 22701647; PMCID: PMC3368874.
    29. McClure-Begley TD, Wageman CR, Grady SR, Marks MJ, McIntosh JM, Collins AC, Whiteaker P. A novel a-conotoxin MII-sensitive nicotinic acetylcholine receptor modulates [(3) H]-GABA release in the superficial layers of the mouse superior colliculus. J Neurochem. 2012 Jul; 122(1):48-57. PMID: 22506481; PMCID: PMC4026281.
    30. Zambrano CA, Salamander RM, Collins AC, Grady SR, Marks MJ. Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures. J Pharmacol Exp Ther. 2012 Aug; 342(2):245-54. PMID: 22532626; PMCID: PMC3400805.
    31. Exley R, McIntosh JM, Marks MJ, Maskos U, Cragg SJ. Striatal a5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum. J Neurosci. 2012 Feb 15; 32(7):2352-6. PMID: 22396410; PMCID: PMC3742968.
    32. Gould TJ, Portugal GS, André JM, Tadman MP, Marks MJ, Kenney JW, Yildirim E, Adoff M. The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation. Neuropharmacology. 2012 Apr; 62(5-6):2118-25. PMID: 22285742; PMCID: PMC3278577.
    33. Ortiz NC, O'Neill HC, Marks MJ, Grady SR. Varenicline blocks ß2*-nAChR-mediated response and activates ß4*-nAChR-mediated responses in mice in vivo. Nicotine Tob Res. 2012 Jun; 14(6):711-9. PMID: 22241831; PMCID: PMC3356295.
    34. Grady SR, Wageman CR, Patzlaff NE, Marks MJ. Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include a5 or a6 subunits and that mediate synaptosomal neurotransmitter release. Neuropharmacology. 2012 Apr; 62(5-6):1935-43. PMID: 22239849; PMCID: PMC3278500.
    35. Gallego X, Molas S, Amador-Arjona A, Marks MJ, Robles N, Murtra P, Armengol L, Fernández-Montes RD, Gratacòs M, Pumarola M, Cabrera R, Maldonado R, Sabrià J, Estivill X, Dierssen M. Overexpression of the CHRNA5/A3/B4 genomic cluster in mice increases the sensitivity to nicotine and modifies its reinforcing effects. Amino Acids. 2012 Aug; 43(2):897-909. PMID: 22101982.
      View in: PubMed
    36. Haydon KC, Roisman GI, Marks MJ, Fraley RC. An empirically derived approach to the latent structure of the Adult Attachment Interview: additional convergent and discriminant validity evidence. Attach Hum Dev. 2011 Sep; 13(5):503-24. PMID: 21838649; PMCID: PMC3221283.
    37. Kota D, Sanjakdar S, Marks MJ, Khabour O, Alzoubi K, Damaj MI. Exploring behavioral and molecular mechanisms of nicotine reward in adolescent mice. Biochem Pharmacol. 2011 Oct 15; 82(8):1008-14. PMID: 21708139; PMCID: PMC3821840.
    38. Baddick CG, Marks MJ. An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants. Biochem Pharmacol. 2011 Oct 15; 82(8):828-41. PMID: 21575611; PMCID: PMC3162045.
    39. Zhao-Shea R, Liu L, Soll LG, Improgo MR, Meyers EE, McIntosh JM, Grady SR, Marks MJ, Gardner PD, Tapper AR. Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area. Neuropsychopharmacology. 2011 Apr; 36(5):1021-32. PMID: 21289604; PMCID: PMC3077271.
    40. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. Habenular a5 nicotinic receptor subunit signalling controls nicotine intake. Nature. 2011 Mar 31; 471(7340):597-601. PMID: 21278726; PMCID: PMC3079537.
    41. Marks MJ, McClure-Begley TD, Whiteaker P, Salminen O, Brown RW, Cooper J, Collins AC, Lindstrom JM. Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain. J Pharmacol Exp Ther. 2011 Apr; 337(1):187-200. PMID: 21228066; PMCID: PMC3063733.
    42. Downing C, Marks MJ, Larson C, Johnson TE. The metabotropic glutamate receptor subtype 5 mediates sensitivity to the sedative properties of ethanol. Pharmacogenet Genomics. 2010 Sep; 20(9):553-64. PMID: 20657349; PMCID: PMC2933419.
    43. Heath CJ, King SL, Gotti C, Marks MJ, Picciotto MR. Cortico-thalamic connectivity is vulnerable to nicotine exposure during early postnatal development through a4/ß2/a5 nicotinic acetylcholine receptors. Neuropsychopharmacology. 2010 Nov; 35(12):2324-38. PMID: 20736992; PMCID: PMC2955839.
    44. Drenan RM, Grady SR, Steele AD, McKinney S, Patzlaff NE, McIntosh JM, Marks MJ, Miwa JM, Lester HA. Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors. J Neurosci. 2010 Jul 21; 30(29):9877-89. PMID: 20660270; PMCID: PMC3390922.
    45. Fraley RC, Marks MJ. Westermarck, Freud, and the incest taboo: does familial resemblance activate sexual attraction? Pers Soc Psychol Bull. 2010 Sep; 36(9):1202-12. PMID: 20647594.
      View in: PubMed
    46. Marks MJ, Meinerz NM, Brown RW, Collins AC. 86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization. Biochem Pharmacol. 2010 Oct 15; 80(8):1238-51. PMID: 20599770; PMCID: PMC2935307.
    47. Grady SR, Drenan RM, Breining SR, Yohannes D, Wageman CR, Fedorov NB, McKinney S, Whiteaker P, Bencherif M, Lester HA, Marks MJ. Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors. Neuropharmacology. 2010 Jun; 58(7):1054-66. PMID: 20114055; PMCID: PMC2849849.
    48. Grady SR, Salminen O, McIntosh JM, Marks MJ, Collins AC. Mouse striatal dopamine nerve terminals express alpha4alpha5beta2 and two stoichiometric forms of alpha4beta2*-nicotinic acetylcholine receptors. J Mol Neurosci. 2010 Jan; 40(1-2):91-5. PMID: 19693710; PMCID: PMC4386732.
    49. Marks MJ, Laverty DS, Whiteaker P, Salminen O, Grady SR, McIntosh JM, Collins AC. John Daly's compound, epibatidine, facilitates identification of nicotinic receptor subtypes. J Mol Neurosci. 2010 Jan; 40(1-2):96-104. PMID: 19672723; PMCID: PMC3042357.
    50. Marks MJ, Wageman CR, Grady SR, Gopalakrishnan M, Briggs CA. Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain. Biochem Pharmacol. 2009 Oct 01; 78(7):795-802. PMID: 19481067; PMCID: PMC2772152.
    51. Breining SR, Bencherif M, Grady SR, Whiteaker P, Marks MJ, Wageman CR, Lester HA, Yohannes D. Evaluation of structurally diverse neuronal nicotinic receptor ligands for selectivity at the alpha6( *) subtype. Bioorg Med Chem Lett. 2009 Aug 01; 19(15):4359-63. PMID: 19560354.
      View in: PubMed
    52. Grady SR, Moretti M, Zoli M, Marks MJ, Zanardi A, Pucci L, Clementi F, Gotti C. Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release. J Neurosci. 2009 Feb 18; 29(7):2272-82. PMID: 19228980; PMCID: PMC2680386.
    53. Collins AC, Salminen O, Marks MJ, Whiteaker P, Grady SR. The road to discovery of neuronal nicotinic cholinergic receptor subtypes. Handb Exp Pharmacol. 2009; (192):85-112. PMID: 19184647.
      View in: PubMed
    54. Drenan RM, Grady SR, Whiteaker P, McClure-Begley T, McKinney S, Miwa JM, Bupp S, Heintz N, McIntosh JM, Bencherif M, Marks MJ, Lester HA. In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors. Neuron. 2008 Oct 09; 60(1):123-36. PMID: 18940593; PMCID: PMC2632732.
    55. Gotti C, Moretti M, Meinerz NM, Clementi F, Gaimarri A, Collins AC, Marks MJ. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits. Mol Pharmacol. 2008 Jun; 73(6):1796-807. PMID: 18337473.
      View in: PubMed
    56. Whiteaker P, Marks MJ, Christensen S, Dowell C, Collins AC, McIntosh JM. Synthesis and characterization of 125I-alpha-conotoxin ArIB[V11L;V16A], a selective alpha7 nicotinic acetylcholine receptor antagonist. J Pharmacol Exp Ther. 2008 Jun; 325(3):910-9. PMID: 18323456.
      View in: PubMed
    57. Teper Y, Whyte D, Cahir E, Lester HA, Grady SR, Marks MJ, Cohen BN, Fonck C, McClure-Begley T, McIntosh JM, Labarca C, Lawrence A, Chen F, Gantois I, Davies PJ, Petrou S, Murphy M, Waddington J, Horne MK, Berkovic SF, Drago J. Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation. J Neurosci. 2007 Sep 19; 27(38):10128-42. PMID: 17881519.
      View in: PubMed
    58. Tapper AR, McKinney SL, Marks MJ, Lester HA. Nicotine responses in hypersensitive and knockout alpha 4 mice account for tolerance to both hypothermia and locomotor suppression in wild-type mice. Physiol Genomics. 2007 Nov 14; 31(3):422-8. PMID: 17712039.
      View in: PubMed
    59. Nashmi R, Xiao C, Deshpande P, McKinney S, Grady SR, Whiteaker P, Huang Q, McClure-Begley T, Lindstrom JM, Labarca C, Collins AC, Marks MJ, Lester HA. Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 2007 Aug 01; 27(31):8202-18. PMID: 17670967.
      View in: PubMed
    60. Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC, Marks MJ. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem Pharmacol. 2007 Oct 15; 74(8):1235-46. PMID: 17825262; PMCID: PMC2735219.
    61. Marks MJ, Meinerz NM, Drago J, Collins AC. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine. Neuropharmacology. 2007 Sep; 53(3):390-405. PMID: 17631923; PMCID: PMC2577786.
    62. Salminen O, Drapeau JA, McIntosh JM, Collins AC, Marks MJ, Grady SR. Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. Mol Pharmacol. 2007 Jun; 71(6):1563-71. PMID: 17341654.
      View in: PubMed
    63. Whiteaker P, Cooper JF, Salminen O, Marks MJ, McClure-Begley TD, Brown RW, Collins AC, Lindstrom JM. Immunolabeling demonstrates the interdependence of mouse brain alpha4 and beta2 nicotinic acetylcholine receptor subunit expression. J Comp Neurol. 2006 Dec 20; 499(6):1016-38. PMID: 17072836.
      View in: PubMed
    64. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM, Zirger JM. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl). 2007 Feb; 190(3):269-319. PMID: 16896961.
      View in: PubMed
    65. Chris Fraley R, Niedenthal PM, Marks M, Brumbaugh C, Vicary A. Adult attachment and the perception of emotional expressions: probing the hyperactivating strategies underlying anxious attachment. J Pers. 2006 Aug; 74(4):1163-90. PMID: 16787432.
      View in: PubMed
    66. Marks MJ, Whiteaker P, Collins AC. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine. Mol Pharmacol. 2006 Sep; 70(3):947-59. PMID: 16728647.
      View in: PubMed
    67. Briggs CA, Gubbins EJ, Marks MJ, Putman CB, Thimmapaya R, Meyer MD, Surowy CS. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors. Mol Pharmacol. 2006 Jul; 70(1):227-40. PMID: 16569710.
      View in: PubMed
    68. Fonck C, Cohen BN, Nashmi R, Whiteaker P, Wagenaar DA, Rodrigues-Pinguet N, Deshpande P, McKinney S, Kwoh S, Munoz J, Labarca C, Collins AC, Marks MJ, Lester HA. Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4* nicotinic receptors. J Neurosci. 2005 Dec 07; 25(49):11396-411. PMID: 16339034.
      View in: PubMed
    69. Fraley RC, Brumbaugh CC, Marks MJ. The evolution and function of adult attachment: a comparative and phylogenetic analysis. J Pers Soc Psychol. 2005 Nov; 89(5):731-46. PMID: 16351365.
      View in: PubMed
    70. Gotti C, Moretti M, Zanardi A, Gaimarri A, Champtiaux N, Changeux JP, Whiteaker P, Marks MJ, Clementi F, Zoli M. Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype alpha3beta2(alpha5 or beta3) enriched in retinocollicular afferents. Mol Pharmacol. 2005 Oct; 68(4):1162-71. PMID: 16049166.
      View in: PubMed
    71. McCallum SE, Collins AC, Paylor R, Marks MJ. Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. Psychopharmacology (Berl). 2006 Mar; 184(3-4):314-27. PMID: 16001112.
      View in: PubMed
    72. Salminen O, Whiteaker P, Grady SR, Collins AC, McIntosh JM, Marks MJ. The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay. Neuropharmacology. 2005 Apr; 48(5):696-705. PMID: 15814104.
      View in: PubMed
    73. Gotti C, Moretti M, Clementi F, Riganti L, McIntosh JM, Collins AC, Marks MJ, Whiteaker P. Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion. Mol Pharmacol. 2005 Jun; 67(6):2007-15. PMID: 15749993.
      View in: PubMed
    74. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC, Lester HA. Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science. 2004 Nov 05; 306(5698):1029-32. PMID: 15528443.
      View in: PubMed
    75. Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC, Grady SR. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol. 2004 Jun; 65(6):1526-35. PMID: 15155845.
      View in: PubMed
    76. Marks MJ, Rowell PP, Cao JZ, Grady SR, McCallum SE, Collins AC. Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology. 2004 Jun; 46(8):1141-57. PMID: 15111021.
      View in: PubMed
    77. McIntosh JM, Azam L, Staheli S, Dowell C, Lindstrom JM, Kuryatov A, Garrett JE, Marks MJ, Whiteaker P. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors. Mol Pharmacol. 2004 Apr; 65(4):944-52. PMID: 15044624.
      View in: PubMed
    78. Tritto T, McCallum SE, Waddle SA, Hutton SR, Paylor R, Collins AC, Marks MJ. Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia. Nicotine Tob Res. 2004 Feb; 6(1):145-58. PMID: 14982698.
      View in: PubMed
    79. Cui C, Booker TK, Allen RS, Grady SR, Whiteaker P, Marks MJ, Salminen O, Tritto T, Butt CM, Allen WR, Stitzel JA, McIntosh JM, Boulter J, Collins AC, Heinemann SF. The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J Neurosci. 2003 Dec 03; 23(35):11045-53. PMID: 14657161.
      View in: PubMed
    80. Quik M, Bordia T, Okihara M, Fan H, Marks MJ, McIntosh JM, Whiteaker P. L-DOPA treatment modulates nicotinic receptors in monkey striatum. Mol Pharmacol. 2003 Sep; 64(3):619-28. PMID: 12920198.
      View in: PubMed
    81. King SL, Marks MJ, Grady SR, Caldarone BJ, Koren AO, Mukhin AG, Collins AC, Picciotto MR. Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior. J Neurosci. 2003 May 01; 23(9):3837-43. PMID: 12736354.
      View in: PubMed
    82. Quik M, Sum JD, Whiteaker P, McCallum SE, Marks MJ, Musachio J, McIntosh JM, Collins AC, Grady SR. Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice. Mol Pharmacol. 2003 May; 63(5):1169-79. PMID: 12695545.
      View in: PubMed
    83. Fonck C, Nashmi R, Deshpande P, Damaj MI, Marks MJ, Riedel A, Schwarz J, Collins AC, Labarca C, Lester HA. Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive alpha 4 nicotinic receptors. J Neurosci. 2003 Apr 01; 23(7):2582-90. PMID: 12684443.
      View in: PubMed
    84. Butt CM, Hutton SR, Marks MJ, Collins AC. Bovine serum albumin enhances nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. J Neurochem. 2002 Oct; 83(1):48-56. PMID: 12358728.
      View in: PubMed
    85. Dobelis P, Marks MJ, Whiteaker P, Balogh SA, Collins AC, Stitzel JA. A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function. Mol Pharmacol. 2002 Aug; 62(2):334-42. PMID: 12130686.
      View in: PubMed
    86. Mogg AJ, Whiteaker P, McIntosh JM, Marks M, Collins AC, Wonnacott S. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. J Pharmacol Exp Ther. 2002 Jul; 302(1):197-204. PMID: 12065717.
      View in: PubMed
    87. Marks MJ, Whiteaker P, Grady SR, Picciotto MR, McIntosh JM, Collins AC. Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice. J Neurochem. 2002 Jun; 81(5):1102-15. PMID: 12065623.
      View in: PubMed
    88. Grady SR, Murphy KL, Cao J, Marks MJ, McIntosh JM, Collins AC. Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions. J Pharmacol Exp Ther. 2002 May; 301(2):651-60. PMID: 11961070.
      View in: PubMed
    89. Whiteaker P, Peterson CG, Xu W, McIntosh JM, Paylor R, Beaudet AL, Collins AC, Marks MJ. Involvement of the alpha3 subunit in central nicotinic binding populations. J Neurosci. 2002 Apr 01; 22(7):2522-9. PMID: 11923417.
      View in: PubMed
    90. Tritto T, Stitzel JA, Marks MJ, Romm E, Collins AC. Variability in response to nicotine in the LSxSS RI strains: potential role of polymorphisms in alpha4 and alpha6 nicotinic receptor genes. Pharmacogenetics. 2002 Apr; 12(3):197-208. PMID: 11927835.
      View in: PubMed
    91. Dukat M, Damaj IM, Young R, Vann R, Collins AC, Marks MJ, Martin BR, Glennon RA. Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations. Eur J Pharmacol. 2002 Jan 25; 435(2-3):171-80. PMID: 11821023.
      View in: PubMed
    92. Grady SR, Meinerz NM, Cao J, Reynolds AM, Picciotto MR, Changeux JP, McIntosh JM, Marks MJ, Collins AC. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. J Neurochem. 2001 Jan; 76(1):258-68. PMID: 11145999.
      View in: PubMed
    93. Marks MJ, Stitzel JA, Grady SR, Picciotto MR, Changeux JP, Collins AC. Nicotinic-agonist stimulated (86)Rb(+) efflux and [(3)H]epibatidine binding of mice differing in beta2 genotype. Neuropharmacology. 2000 Oct; 39(13):2632-45. PMID: 11044733.
      View in: PubMed
    94. Breese CR, Lee MJ, Adams CE, Sullivan B, Logel J, Gillen KM, Marks MJ, Collins AC, Leonard S. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology. 2000 Oct; 23(4):351-64. PMID: 10989262.
      View in: PubMed
    95. Whiteaker P, Jimenez M, McIntosh JM, Collins AC, Marks MJ. Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine. Br J Pharmacol. 2000 Oct; 131(4):729-39. PMID: 11030722; PMCID: PMC1572375.
    96. Whiteaker P, McIntosh JM, Luo S, Collins AC, Marks MJ. 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol Pharmacol. 2000 May; 57(5):913-25. PMID: 10779374.
      View in: PubMed
    97. Stitzel JA, Jimenez M, Marks MJ, Tritto T, Collins AC. Potential role of the alpha4 and alpha6 nicotinic receptor subunits in regulating nicotine-induced seizures. J Pharmacol Exp Ther. 2000 Apr; 293(1):67-74. PMID: 10734154.
      View in: PubMed
    98. Whiteaker P, Marks MJ, Grady SR, Lu Y, Picciotto MR, Changeux JP, Collins AC. Pharmacological and null mutation approaches reveal nicotinic receptor diversity. Eur J Pharmacol. 2000 Mar 30; 393(1-3):123-35. PMID: 10771005.
      View in: PubMed
    99. Lu Y, Marks MJ, Collins AC. Desensitization of nicotinic agonist-induced [3H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists. J Pharmacol Exp Ther. 1999 Dec; 291(3):1127-34. PMID: 10565833.
      View in: PubMed
    100. Whiteaker P, Davies AR, Marks MJ, Blagbrough IS, Potter BV, Wolstenholme AJ, Collins AC, Wonnacott S. An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur J Neurosci. 1999 Aug; 11(8):2689-96. PMID: 10457165.
      View in: PubMed
    101. Marks MJ, Whiteaker P, Calcaterra J, Stitzel JA, Bullock AE, Grady SR, Picciotto MR, Changeux JP, Collins AC. Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. J Pharmacol Exp Ther. 1999 May; 289(2):1090-103. PMID: 10215692.
      View in: PubMed
    102. Lu Y, Grady S, Marks MJ, Picciotto M, Changeux JP, Collins AC. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J Pharmacol Exp Ther. 1998 Nov; 287(2):648-57. PMID: 9808692.
      View in: PubMed
    103. Marks MJ, Smith KW, Collins AC. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. J Pharmacol Exp Ther. 1998 Apr; 285(1):377-86. PMID: 9536034.
      View in: PubMed
    104. Grady SR, Grun EU, Marks MJ, Collins AC. Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment. J Pharmacol Exp Ther. 1997 Jul; 282(1):32-43. PMID: 9223537.
      View in: PubMed
    105. Breese CR, Marks MJ, Logel J, Adams CE, Sullivan B, Collins AC, Leonard S. Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther. 1997 Jul; 282(1):7-13. PMID: 9223534.
      View in: PubMed
    106. Bullock AE, Clark AL, Grady SR, Robinson SF, Slobe BS, Marks MJ, Collins AC. Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J Neurochem. 1997 Jun; 68(6):2412-23. PMID: 9166735.
      View in: PubMed
    107. Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, Marks MJ, Rose GM. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology. 1996 Aug; 15(2):152-62. PMID: 8840351.
      View in: PubMed
    108. Marks MJ, Pauly JR, Grun EU, Collins AC. ST/b and DBA/2 mice differ in brain alpha-bungarotoxin binding and alpha 7 nicotinic receptor subunit mRNA levels: a quantitative autoradiographic analysis. Brain Res Mol Brain Res. 1996 Jul; 39(1-2):207-22. PMID: 8804729.
      View in: PubMed
    109. Marks MJ, Robinson SF, Collins AC. Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes. J Pharmacol Exp Ther. 1996 Jun; 277(3):1383-96. PMID: 8667201.
      View in: PubMed
    110. Robinson SF, Marks MJ, Collins AC. Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology (Berl). 1996 Apr; 124(4):332-9. PMID: 8739548.
      View in: PubMed
    111. Marks MJ, Bullock AE, Collins AC. Sodium channel blockers partially inhibit nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes. J Pharmacol Exp Ther. 1995 Aug; 274(2):833-41. PMID: 7636747.
      View in: PubMed
    112. Marks MJ, Grady SR, Yang JM, Lippiello PM, Collins AC. Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes. J Neurochem. 1994 Dec; 63(6):2125-35. PMID: 7964732.
      View in: PubMed
    113. Smolen A, Marks MJ, DeFries JC, Henderson ND. Individual differences in sensitivity to nicotine in mice: response to six generations of selective breeding. Pharmacol Biochem Behav. 1994 Nov; 49(3):531-40. PMID: 7862704.
      View in: PubMed
    114. Firestone JA, Marks MJ, Gerhardt GA, Browning MD. ABT-200, a norepinephrine uptake inhibitor, blocks Ca2+ signals in chromaffin cells. Eur J Pharmacol. 1994 Oct 14; 269(2):177-82. PMID: 7851493.
      View in: PubMed
    115. Collins AC, Luo Y, Selvaag S, Marks MJ. Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion. J Pharmacol Exp Ther. 1994 Oct; 271(1):125-33. PMID: 7965705.
      View in: PubMed
    116. Robinson SF, Pauly JR, Marks MJ, Collins AC. An analysis of response to nicotine infusion using an automated radiotelemetry system. Psychopharmacology (Berl). 1994 Jun; 115(1-2):115-20. PMID: 7862882.
      View in: PubMed
    117. Grady SR, Marks MJ, Collins AC. Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes. J Neurochem. 1994 Apr; 62(4):1390-8. PMID: 8133269.
      View in: PubMed
    118. Luo Y, Marks MJ, Collins AC. Genotype regulates the development of tolerance to ethanol and cross-tolerance to nicotine. Alcohol. 1994 Mar-Apr; 11(2):167-76. PMID: 8204204.
      View in: PubMed
    119. Bhat RV, Marks MJ, Collins AC. Effects of chronic nicotine infusion on kinetics of high-affinity nicotine binding. J Neurochem. 1994 Feb; 62(2):574-81. PMID: 8294920.
      View in: PubMed
    120. Collins AC, Romm E, Selvaag S, Turner S, Marks MJ. A comparison of the effects of chronic nicotine infusion on tolerance to nicotine and cross-tolerance to ethanol in long- and short-sleep mice. J Pharmacol Exp Ther. 1993 Sep; 266(3):1390-7. PMID: 8371144.
      View in: PubMed
    121. Marks MJ, Grady SR, Collins AC. Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther. 1993 Sep; 266(3):1268-76. PMID: 8371136.
      View in: PubMed
    122. Marks MJ, Farnham DA, Grady SR, Collins AC. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J Pharmacol Exp Ther. 1993 Feb; 264(2):542-52. PMID: 8437106.
      View in: PubMed
    123. Grady S, Marks MJ, Wonnacott S, Collins AC. Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem. 1992 Sep; 59(3):848-56. PMID: 1494911.
      View in: PubMed
    124. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF, Collins AC. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci. 1992 Jul; 12(7):2765-84. PMID: 1613557.
      View in: PubMed
    125. Marks MJ, Campbell SM, Romm E, Collins AC. Genotype influences the development of tolerance to nicotine in the mouse. J Pharmacol Exp Ther. 1991 Oct; 259(1):392-402. PMID: 1920127.
      View in: PubMed
    126. Pauly JR, Marks MJ, Gross SD, Collins AC. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther. 1991 Sep; 258(3):1127-36. PMID: 1890617.
      View in: PubMed
    127. Bhat RV, Turner SL, Selvaag SR, Marks MJ, Collins AC. Regulation of brain nicotinic receptors by chronic agonist infusion. J Neurochem. 1991 Jun; 56(6):1932-9. PMID: 2027007.
      View in: PubMed
    128. Smolen A, Marks MJ. Genetic selections for nicotine and cocaine sensitivity in mice. J Addict Dis. 1991; 10(1-2):7-28. PMID: 1648412.
      View in: PubMed
    129. Collins AC, Marks MJ. Progress towards the development of animal models of smoking-related behaviors. J Addict Dis. 1991; 10(1-2):109-26. PMID: 2065112.
      View in: PubMed
    130. Bhat RV, Turner SL, Marks MJ, Collins AC. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion. J Pharmacol Exp Ther. 1990 Oct; 255(1):187-96. PMID: 2213555.
      View in: PubMed
    131. Collins AC, Campbell SM, Romm E, Marks MJ. A comparison of sensitivity to oxotremorine and muscarinic receptors in LS and SS mice. Alcohol Clin Exp Res. 1990 Aug; 14(4):605-15. PMID: 2221290.
      View in: PubMed
    132. de Fiebre CM, Marks MJ, Collins AC. Ethanol-nicotine interactions in long-sleep and short-sleep mice. Alcohol. 1990 May-Jun; 7(3):249-57. PMID: 2331320.
      View in: PubMed
    133. Fiedler EP, Marks MJ, Collins AC. Postnatal development of two nicotinic cholinergic receptors in seven mouse brain regions. Int J Dev Neurosci. 1990; 8(5):533-40. PMID: 2281814.
      View in: PubMed
    134. Collins AC, Bhat RV, Pauly JR, Marks MJ. Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. Ciba Found Symp. 1990; 152:68-82; discussion 82-6. PMID: 2209260.
      View in: PubMed
    135. Romm E, Lippiello PM, Marks MJ, Collins AC. Purification of L-[3H]nicotine eliminates low affinity binding. Life Sci. 1990; 46(13):935-43. PMID: 2329919.
      View in: PubMed
    136. Marks MJ, Stitzel JA, Collins AC. Genetic influences on nicotine responses. Pharmacol Biochem Behav. 1989 Jul; 33(3):667-78. PMID: 2587608.
      View in: PubMed
    137. Marks MJ, Romm E, Campbell SM, Collins AC. Variation of nicotinic binding sites among inbred strains. Pharmacol Biochem Behav. 1989 Jul; 33(3):679-89. PMID: 2587609.
      View in: PubMed
    138. Pauly JR, Stitzel JA, Marks MJ, Collins AC. An autoradiographic analysis of cholinergic receptors in mouse brain. Brain Res Bull. 1989 Feb; 22(2):453-9. PMID: 2706548.
      View in: PubMed
    139. Collins AC, Marks MJ, Pauly JR. Differential effect of chronic nicotine treatment on nicotinic receptor numbers in various brain regions of mice. J Subst Abuse. 1989; 1(3):273-86. PMID: 7580219.
      View in: PubMed
    140. Collins AC, Miner LL, Marks MJ. Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse. Pharmacol Biochem Behav. 1988 May; 30(1):269-78. PMID: 3174752.
      View in: PubMed
    141. Stitzel JA, Campbell SM, Collins AC, Marks MJ. Sulfhydryl modification of two nicotinic binding sites in mouse brain. J Neurochem. 1988 Mar; 50(3):920-8. PMID: 3339366.
      View in: PubMed
    142. Collins AC, Burch JB, de Fiebre CM, Marks MJ. Tolerance to and cross tolerance between ethanol and nicotine. Pharmacol Biochem Behav. 1988 Feb; 29(2):365-73. PMID: 3362930.
      View in: PubMed
    143. Burch JB, de Fiebre CM, Marks MJ, Collins AC. Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents. Psychopharmacology (Berl). 1988; 95(4):452-8. PMID: 3145516.
      View in: PubMed
    144. Marks MJ, Romm E, Collins AC. Mouse brain ATPase activities after chronic nicotine infusion. Biochem Pharmacol. 1987 Oct 01; 36(19):3318-20. PMID: 2822051.
      View in: PubMed
    145. Marks MJ, Romm E, Collins AC. Genetic influences on tolerance development with chronic oxotremorine infusion. Pharmacol Biochem Behav. 1987 Aug; 27(4):723-32. PMID: 3659096.
      View in: PubMed
    146. Marks MJ, Stitzel JA, Collins AC. Influence of kinetics of nicotine administration on tolerance development and receptor levels. Pharmacol Biochem Behav. 1987 Jul; 27(3):505-12. PMID: 2821553.
      View in: PubMed
    Marks's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)